Equitec Proprietary Markets, LLC Surface Oncology, Inc. Put Options Transaction History

Equitec Proprietary Markets, LLC

  • $92.9 Million
  • Q3 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Jul 12, 2023
BUY
$0.57 - $0.88 $11,399 - $17,600
20,000 New
20,000 $17,000

Others Institutions Holding SURF

# of Institutions
2
Shares Held
315K
Call Options Held
0
Put Options Held
0
View Full List

About Surface Oncology, Inc.

SURF Quotes by TradingView
  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Equitec Proprietary Markets, LLC Portfolio

Follow Equitec Proprietary Markets, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email